These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15156443)

  • 21. Methicillin-resistant Staphylococcus aureus: misinterpretation and misrepresentation of active detection and isolation.
    Farr BM; Jarvis WR
    Clin Infect Dis; 2008 Nov; 47(9):1238-9; author reply 1239-40. PubMed ID: 18831705
    [No Abstract]   [Full Text] [Related]  

  • 22. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients.
    Kaplan SL
    Infect Dis Clin North Am; 2005 Sep; 19(3):747-57. PubMed ID: 16102659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit: impact of infection control measures].
    Lepelletier D; Caillon J; Corvec S; Rozé JC; Gras C
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S100-2. PubMed ID: 18598855
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evolution of methicillin resistance in Staphylococcus aureus in Cordoba (Spain) in the years 2002-2005].
    García-Mayorgas AD; Causse M; Rodríguez F; Ibarra A; Solis F; Casal M
    Rev Esp Quimioter; 2005 Dec; 18(4):328-30. PubMed ID: 16446793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two studies feed the debate on active surveillance for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci carriage: to screen or not to screen?
    Talbot TR
    J Infect Dis; 2007 Feb; 195(3):314-7. PubMed ID: 17205467
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
    Humphreys H; Smyth EG
    J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985
    [No Abstract]   [Full Text] [Related]  

  • 27. Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Creech CB; Beekmann SE; Chen Y; Polgreen PM
    Pediatr Infect Dis J; 2008 Mar; 27(3):270-2. PubMed ID: 18277924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-acquired methicillin-resistant Staphylococcus aureus infections.
    Palavecino E
    Clin Lab Med; 2004 Jun; 24(2):403-18. PubMed ID: 15177847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection.
    Jones TF; Creech CB; Erwin P; Baird SG; Woron AM; Schaffner W
    Clin Infect Dis; 2006 May; 42(9):e76-8. PubMed ID: 16586378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and update.
    Gorwitz RJ
    Pediatr Infect Dis J; 2008 Oct; 27(10):925-6. PubMed ID: 18820590
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.
    Hamilton SM; Bryant AE; Carroll KC; Lockary V; Ma Y; McIndoo E; Miller LG; Perdreau-Remington F; Pullman J; Risi GF; Salmi DB; Stevens DL
    Clin Infect Dis; 2007 Dec; 45(12):1550-8. PubMed ID: 18190315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of methicillin-resistant Staphylococcus aureus on ENT practice.
    Nixon IJ; Bingham BJ
    J Laryngol Otol; 2006 Sep; 120(9):713-7. PubMed ID: 16700956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methicillin-resistant Staphylococcus aureus--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Nov; 30(45):557-9. PubMed ID: 6795434
    [No Abstract]   [Full Text] [Related]  

  • 34. Methicillin-resistant Staphylococcus aureus: a community concern.
    Hedge DD
    S D Med; 2006 Oct; 59(10):433, 435. PubMed ID: 17124921
    [No Abstract]   [Full Text] [Related]  

  • 35. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
    Gould IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery.
    Mastoraki A; Kriaras I; Douka E; Mastoraki S; Stravopodis G; Geroulanos S
    Interact Cardiovasc Thorac Surg; 2008 May; 7(3):452-6. PubMed ID: 18346978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):586-8; quiz 589-92. PubMed ID: 15761788
    [No Abstract]   [Full Text] [Related]  

  • 38. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
    Sharma A; Philpott C; Pope L; McKiernan D
    J Laryngol Otol; 2007 May; 121(5):415-8. PubMed ID: 17040604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methicillin-resistant Staphylococcus aureus and beyond: what's new in the world of the golden staph?
    Marshall C; Kossmann T; Wesselingh S; Spelman D
    ANZ J Surg; 2004 Jun; 74(6):465-9. PubMed ID: 15191484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methicillin resistant Staphylococcus aureus infections-implications in hospital infection control.
    Krishna BV; Patil A; Chandrasekhar MR
    Indian J Public Health; 2007; 51(1):43-6. PubMed ID: 18232141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.